Bill Details - HB1747 (2018)

HB 1747-FN - AS INTRODUCED

 

 

2018 SESSION

18-2400

01/04

 

HOUSE BILL 1747-FN

 

AN ACT relative to packaging of certain controlled drugs.

 

SPONSORS: Rep. Migliore, Graf. 9

 

COMMITTEE: Health, Human Services and Elderly Affairs

 

-----------------------------------------------------------------

 

ANALYSIS

 

This bill requires manufacturers to pre-package class II controlled drugs which are going to be dispensed in New Hampshire in blister packs with serial numbers on each pill.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

18-2400

01/04

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Eighteen

 

AN ACT relative to packaging of certain controlled drugs.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1  New Section; Packaging of Class II Controlled Drugs.  Amend RSA 318-B by inserting after section 9 the following new section:

318-B:9-a  Packaging of Class II Controlled Drugs.  Manufacturers packaging class II controlled drugs to be dispensed in New Hampshire shall pre-package such drugs in individual dose blister packs with traceable inventory serial numbers on each pill.  

2  Effective Date.  This act shall take effect January 1, 2019.

 

LBAO

18-2400

11/17/17

 

HB 1747-FN- FISCAL NOTE

AS INTRODUCED

 

AN ACT relative to packaging of certain controlled drugs.

 

FISCAL IMPACT:      [ X ] State              [    ] County               [    ] Local              [    ] None

 

 

 

Estimated Increase / (Decrease)

STATE:

FY 2019

FY 2020

FY 2021

FY 2022

   Appropriation

$0

$0

$0

$0

   Revenue

Indeterminable Increase

Indeterminable Increase

Indeterminable Increase

Indeterminable Increase

   Expenditures

Indeterminable Increase

Indeterminable Increase

Indeterminable Increase

Indeterminable Increase

Funding Source:

  [ X ] General            [    ] Education            [    ] Highway           [ X ] Other - Federal Medicaid Revenue

 

 

 

 

 

METHODOLOGY:

The Department of Health and Human Services assumes implementation of the packaging and tracking requirements in New Hampshire could cause some manufacturers to cease distributing class II drugs in New Hampshire or increase their prices to cover the additional packaging, tracking and distribution costs.  The increase in costs to the Medicaid program for class II controlled drugs cannot be determined.  Medicaid expenditures are paid with a combination of state and federal funds, therefore any increase in Medicaid expenditures will also increase federal restricted revenue by 50% of the expenditure increase.   

 

The Office of Professional Licensure and Certification states this bill would have no fiscal impact on the Office or on the Board of Pharmacy.

 

AGENCIES CONTACTED:

Department of Health and Human Services and Office of Professional Licensure and Certification

 

Docket

Date Status
Jan. 3, 2018 Introduced 01/03/2018 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 22
Jan. 23, 2018 Public Hearing: 01/23/2018 11:00 AM LOB 205
Jan. 24, 2018 Executive Session: 01/24/2018 LOB 205
Feb. 7, 2018 Committee Report: Inexpedient to Legislate for 02/07/2018 (Vote 18-1; CC) HC 5 P. 9
Committee Report: Inexpedient to Legislate (Vote 18-1; CC)
Feb. 8, 2018 Inexpedient to Legislate: MA VV 02/08/2018 HJ 3 P. 7

Action Dates

Date Body Type
Jan. 23, 2018 House Hearing
Jan. 24, 2018 House Exec Session
House Floor Vote
Feb. 7, 2018 House Floor Vote

Bill Text Revisions

HB1747 Revision: 2209 Date: Nov. 20, 2017, 8:48 a.m.